drugset / Trial / NCT07534475

Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT

NCT07534475

Not yet recruiting 20 enrolled Medipol University
NaSingle-groupOpen-labelDiagnostic

Summary

This prospective, open-label clinical trial aims to compare a novel "Venous Tourniquet with Regional Low-Dose Sugammadex" method against the gold standard "Arterial Tourniquet" (Isolated Forearm Technique - IFT) for monitoring motor seizure activity during Electroconvulsive Therapy (ECT). Using a within-subject (intra-individual) design, each of the 40 enrolled patients will receive an arterial tourniquet on one arm and a venous tourniquet on the other arm simultaneously. The study will evaluate clinical efficacy in observing motor seizures, comparing the duration and visibility between the two limbs of the same patient, as well as assessing overall patient comfort and hemodynamics.

Timeline

Start
2026-04-20
Primary completion
2026-05-30
Completion
2026-06-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Sugammadex Other / unclassified 0.3 mg/kg Intravenous